Loading clinical trials...
Loading clinical trials...
A Phase IV Open-label Trial Assessing the Impact on Skin Quality, Hydration, and Barrier of Three (3) Hydrafacial Treatments in Adults of Fitzpatrick Skin Types I-VI
Conditions
Interventions
HydraFacial Syndeo System
ReGen-GF
+1 more
Locations
2
United States
Austin Institute for Clinical Research, Inc.
Houston, Texas, United States
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas, United States
Start Date
November 20, 2023
Primary Completion Date
October 9, 2024
Completion Date
October 9, 2024
Last Updated
October 24, 2024
Lead Sponsor
Austin Institute for Clinical Research
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions